In Situ Swelling Formulation of Glycerol-Monooleate-Derived Lyotropic Liquid Crystals Proposed for Local Vaginal Application

Molecules. 2022 Sep 23;27(19):6295. doi: 10.3390/molecules27196295.

Abstract

Hydrogels have been extensively investigated to identify innovative formulations that can fulfill all the necessary purposes to improve local vaginal therapy through the mucosa. Herein, we propose in situ-forming lyotropic liquid crystals (LLCs) derived from a cheap and GRAS (generally recognized as safe) ingredient as an intravaginal delivery system. The system consists of a precursor solution loaded with sertaconazole nitrate as a model drug, which is able to easily swell in a stable three-dimensional structure by absorbing simulated vaginal fluid. Under polarized light microscopy the precursor solution and the formed phase of LLCs showed the typical textures belonging to anisotropic and an isotropic mesophases, respectively. A deep rheological investigation by Kinexus® Pro proved the stability and strength of the cubic phase, as well as its potential in mucoadhesion. In vitro degradation studies showed a slow matrix erosion, consistent with data obtained from lipophilic drug release studies in simulated vaginal fluid. Therefore, the suggested cubic phase based on lyotropic liquid crystals could represent a valid proposal as a vaginal drug delivery system due to its characteristics of resistance, adhesion and the possibility of providing a slow and controlled release of drugs directly at the administration site.

Keywords: Kinexus® Pro rheometer; cubic phase precursor; in situ forming formulation; sertaconazole nitrate; spontaneous degradation; vaginal mucosa.

MeSH terms

  • Delayed-Action Preparations
  • Drug Liberation
  • Female
  • Glycerol
  • Humans
  • Hydrogels
  • Liquid Crystals* / chemistry

Substances

  • Delayed-Action Preparations
  • Hydrogels
  • Glycerol

Grants and funding

This research received no external funding.